Injection of GIP and GLP-2 may reduce bone resorption biomarker CTX in type 2 diabetes patients: Study
Denmark: A recent study published in The Journal of Clinical Endocrinology and Metabolism has shed light on the effects of exogenous glucose-dependent insulinotropic polypeptide (GIP) and...
Source: medicaldialogues.in